Aripraxole for Drug-induced Psychosis in Parkinson Disease: Preliminary Experience

Clinical Neuropharmacology

Volumn 27, Issue 1, 2004, Pages 4-5

  Fernandez, Hubert H ^a,c   Trieschmann, Martha E ^b   Friedman, Joseph H ^b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b BROWN UNIVERSITY   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; PIPERAZINE DERIVATIVE; QUINOLONE DERIVATIVE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONFUSION; DOSE RESPONSE; DRUG WITHDRAWAL; EXTRAPYRAMIDAL SYMPTOM; GENERAL CONDITION DETERIORATION; GENERAL CONDITION IMPROVEMENT; HUMAN; INSOMNIA; MOTOR PERFORMANCE; PARKINSON DISEASE; PRIORITY JOURNAL; PSYCHOSIS; RESTLESSNESS; TREATMENT FAILURE; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DEMENTIA; FOLLOW UP; MALE; MENTAL DISEASE; MIDDLE AGED;

AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; DEMENTIA; FOLLOW-UP STUDIES; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; PARKINSON DISEASE; PIPERAZINES; QUINOLONES;

EID: 1442300056     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002826-200401000-00003     Document Type: Article

References (9)

1. Kapur S, Seeman P. Does fast dissociation from the dopamine D2 receptor explain the action of atypical antipsychotics?: A new hypothesis. Am J Psychiatry. 2001;158:360-369.
2. Meltzer H, Matsubara S, Lee J. The ratios of serotonin-2 and dopamine-2 affinities differentiate atypical and typical antipsychotic drugs. Psychopharmacology Bulletin 1989;25.
3. Ichikawa J, Ishii H, Bonaccorso S, et al. 5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release. JNeurochem. 2001;76:1521-1531.
4. Meltzer H. Action of atypical antipsychotics. [Letter] Am J Psychiatry. 2002;159:153-154.
5. Company B-MS. Otsuka America Pharmaceutical I. Abilify (Aripiprazole) Package Insert. 2002.
6. Fernandez H, Trieschmann M, Friedman J. The Safety of Atypical Antipsychotics. Drug Safety. 2003;26(9):643:659.
7. Fernandez HH, Friedman JH. The Role of Atypical Antipsychotics in the Treatment of Movement Disorders. CNS Drugs. 1999;11:467-483.
8. American Psychiatric Association. Diagnostic and Statistical Manual of mental Disorders, Fourth Edition. Washington DC, American Psychiatric Association, 1994.
9. Fernandez HH, Trieschmann ME, Burke MA, et al. Long-Term Quetiapine Use for Drug-Induced Psychosis Among Parkinsonian Patients. Mov Disord. 2003;18:510-514.